Cannabis
New inhalable drug containing CBD designed for efficacious treatment of brain injuries
Hi, what are you looking for?
Mugglehead Investment Magazine
Research
Psychedelics
Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures
Analysis
New survey outlines that Texans prefer cannainoid treatment for chronic pain over opioids
Research
Researchers also found studies saw a reduction of serotonin following antidepressant use
Psychedelics
Initial dose of FT-104 given in Adelaide, company announces name change
Psychedelics
Canadian company continues to develop its presence in the clinical psychedelic sector
Cannabis
International cannabis concentrate sector anticipated to triple in value by 2030
Psychedelics
Psychedelic Fundamentals course to provide broad overview of a vast topic
Industry update
Flexible new curriculum designed to help students into cannabis career paths
Psychedelics
FDA-approved psilocin study in California said to be first of its kind for industry
